In the pooled data from the pivotal STEP trials (STEP 2, 3 and 4), 3% of adults on semaglutide 2.4 mg lost a measurable amount of hair, compared with 1% on placebo
The thinning of the blood can increase the risk of bruising
Patients with Aetna plans that do not cover Zepbound may be eligible to pay as little as $650 for a 1-month supply of Zepbound, saving up to $469 per month
Novo Nordisk leads with a comprehensive GLP-1 portfolio including Ozempic, Rybelsus, and Wegovy, offering strong coverage across diabetes, obesity, and cardiovascular risk management
I certainly expect that tirzepatide will get an obesity licence
In our April 5, 2024, update above, our attorneys talk about the type of cases we are seeing in this litigation